(19)
(11) EP 4 680 295 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24704219.5

(22) Date of filing: 14.02.2024
(51) International Patent Classification (IPC): 
A61L 29/08(2006.01)
A61L 29/16(2006.01)
A61K 31/00(2006.01)
 A61L 29/14(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61L 29/085; A61L 29/145; A61L 29/16; A61L 2300/406; A61L 2300/428; A61L 2400/10; A61K 9/0014; A61K 31/519; A61K 31/65; A61K 31/115; A61K 38/00
 
C-Sets:
  1. A61K 31/115, A61K 2300/00;
  2. A61L 29/085, C08L 29/12;
  3. A61L 29/085, C08L 33/24;
  4. A61K 31/519, A61K 2300/00;
  5. A61K 31/65, A61K 2300/00;
(86) International application number:
PCT/EP2024/053778
(87) International publication number:
WO 2024/188572 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.03.2023 EP 23162106
28.03.2023 EP 23164834

(71) Applicant: CM4Cure s.a.
4000 Liège (BE)

(72) Inventors:
  • OURY, Cécile
    4000 Liège (BE)
  • LANCELLOTTI, Patrizio
    4000 Liège (BE)
  • AQIL, Abdelhafid
    4000 Liège (BE)
  • DITKOWSKI, Bartosz
    4000 Liège (BE)

(74) Representative: Barker Brettell LLP 
100 Hagley Road Edgbaston
Birmingham B16 8QQ
Birmingham B16 8QQ (GB)

   


(54) NANOGEL COMPRISING BIOACTIVE MOLECULES, THERAPEUTIC MOLECULES OR DRUGS TOGETHER WITH AN AMPHIPHILIC MOLECULE